Advertisement
Cancer patients who have diabetes may suffer worse heart damage from chemotherapy

Chemo-Related Cardiotoxicity Worse in Diabetes Patients

0
Those with diabetes showed more early warning signs of heart failure
The Drug Enforcement Administration has announced critical changes in its registration renewal process

DEA Announces Critical Changes in Registration Renewal Process

0
The ability to renew a registration online after the expiration date will no longer be available
For hepatitis C virus-infected patients

Diabetes Ups Risk of HCC, Death in Patients With Hepatitis C

0
Diabetes increases risk of hepatocellular carcinoma development in patients with HCV
For patients with type 2 diabetes mellitus

Long-Term DPP4-Inhibitor Use Not Tied to Fracture Risk in T2DM

0
No increase in risk of any fracture, osteoporotic or hip fractures with continuous long-term use
In older adults

Dysglycemia Affects Brain Structure, Cognition in Seniors

0
Brain infarcts, white matter hyperintensities volume up; total white matter down
For patients with coronary heart disease

Noncardiovascular Cause of Death More Common in CHD Patients

0
Predictors of noncardiac death include older age, inducible ischemia, higher heart rate, statin nonuse
For adults with metabolic syndrome

Pioglitazone Improves Whole-Body Aerobic Capacity in MetS

0
Improvements in intramyocellular lipid content, skeletal muscle high-energy phosphate metabolism
Pokémon Go provided a slight

No Long-Term Increase in Exercise Levels for Pokémon Go

0
Study found the virtual reality game got adults moving -- but only for a while
Lower-income patients with diabetes and private insurance with a low or high deductible have reduced medical service use

Medical Service Use Down With Deductibles in Diabetes

0
For low-income patients with diabetes, deductible cuts primary care use, check-ups, specialty visits
Outcomes-based pricing for novel and expensive biopharmaceuticals is supported in an Ideas and Opinions piece published online Dec. 13 in the Annals of Internal Medicine.

Outcomes-Based Pricing Suggested for New, Costly Drugs

0
Strategy would compel manufacturers and insurers to share accountability for clinical outcomes